The influence of GH on ICI treatment of tumor seems to be gastric cancer specific; we evaluated its effect on hepatocellular carcinoma and esophageal cancer patients with ICI treatment, but no association could be found (Table S3). The gene discussed is GH1; the disease is esophageal cancer.